US Map / Illinois
State IL

Clinical Trials in Illinois

Illinois is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Illinois and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 398 actively recruiting studies with Illinois sites out of 398 registered in total. The busiest research areas in Illinois are Schizophrenia, Obesity, Breast Cancer. Leading sponsors running trials in the state include University of Chicago, Northwestern University, University of Illinois Chicago. By stage, Illinois trials break down as Phase 1 (55), Phase 2 (104), Phase 3 (106), Phase 4 (15).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
398
Recruiting Now
398
← Back to US Map
Top Conditions in Illinois
Schizophrenia (7)Obesity (7)Breast Cancer (6)Stroke (6)Ovarian Cancer (5)Prostate Cancer (5)Heart Failure (5)Acute Myeloid Leukemia (4)Cancer (4)Cervical Cancer (4)Liver Transplant (4)Ulcerative Colitis (4)

Frequently Asked Questions — Clinical Trials in Illinois

How many clinical trials are currently recruiting in Illinois?
ClinicalMetric currently tracks 398 actively recruiting clinical trials with at least one location in Illinois. The total number of registered studies—including active but not currently enrolling trials—is 398. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Illinois?
Illinois hosts clinical trials across a broad range of medical conditions, including Schizophrenia, Obesity, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Illinois serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Illinois?
To join a clinical trial in Illinois, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Illinois maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Illinois

NCT07583498 N/A
Recruiting
Spasticity in SCI Following Acute Intermittent Hypoxia
Condition
Spinal Cord Injuries (SCI)
Enrollment
10 pts
Location
United States
Sponsor
Zev Rymer
View Trial →
NCT07028489 N/A
Recruiting
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or...
Condition
Non Small Cell Lung Cancer
Enrollment
130 pts
Location
United States
Sponsor
N-Power Medicine
View Trial →
NCT06252649 Phase 3
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevac...
Condition
Metastatic Colorectal Cancer
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT06613438 N/A
Recruiting
Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disea...
Condition
GERD (Gastroesophageal Reflux Disease)
Enrollment
84 pts
Location
United States, Israel
Sponsor
Gerd Care Medical Ltd
View Trial →
NCT05911568 N/A
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disab...
Condition
Stroke
Enrollment
1,060 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
View Trial →
NCT07788638 N/A
Recruiting
Non-Invasive Neurofeedback Training to Alleviate Tinnitus Distress
Condition
Tinnitus Aggravated
Enrollment
20 pts
Location
United States
Sponsor
University of Illinois at Urba
View Trial →
NCT07700966 N/A
Recruiting
A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With P...
Condition
Recessive Dystrophic Epidermolysis Bullosa
Enrollment
250 pts
Location
United States
Sponsor
Abeona Therapeutics, Inc
View Trial →
NCT06957366 N/A
Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patien...
Condition
Atrial Fibrillation (AF)
Enrollment
920 pts
Location
United States, Belgium, Canada
Sponsor
McMaster University
View Trial →
NCT06213649 Phase 3
Recruiting
Parasitic Ulcer Treatment Trial
Condition
Acanthamoeba Keratitis
Enrollment
232 pts
Location
United States, Brazil, India
Sponsor
Jeremy Keenan, MD, MPH
View Trial →
NCT03686124 Phase 1, Phase 2
Recruiting
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in R...
Condition
Refractory Cancer
Enrollment
375 pts
Location
United States, Germany
Sponsor
Immatics US, Inc.
View Trial →
NCT03729180 N/A
Recruiting
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
Condition
Surgery
Enrollment
1,900 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07277946 N/A
Recruiting
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Saf...
Condition
Hernia
Enrollment
240 pts
Location
United States
Sponsor
Tissium
View Trial →
NCT06930755 Phase 1
Recruiting
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
Condition
Ovarian Cancer
Enrollment
24 pts
Location
United States
Sponsor
Nerviano Medical Sciences
View Trial →
NCT06765668 Phase 4
Recruiting
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Partici...
Condition
Parkinson Disease
Enrollment
220 pts
Location
United States
Sponsor
Impax Laboratories, LLC
View Trial →
NCT06976268 Phase 2, Phase 3
Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment...
Condition
Parkinson Disease
Enrollment
550 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
View Trial →
NCT07593391 Phase 3
Recruiting
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid S...
Condition
Phelan-McDermid Syndrome
Enrollment
180 pts
Location
United States
Sponsor
Neuren Pharmaceuticals Limited
View Trial →
NCT07114874 Phase 3
Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizoph...
Condition
Schizophrenia
Enrollment
600 pts
Location
United States, Bulgaria, Puerto Rico
Sponsor
Neurocrine Biosciences
View Trial →
NCT06608823 N/A
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Condition
Aortic Regurgitation
Enrollment
1,016 pts
Location
United States
Sponsor
JenaValve Technology, Inc.
View Trial →
NCT07227246 Phase 3
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Condition
Intracerebral Hemorrhage
Enrollment
350 pts
Location
United States, Canada, Germany
Sponsor
Joseph Broderick, MD
View Trial →
NCT04363684 N/A
Recruiting
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Condition
Frontotemporal Lobar Degeneration (FTLD)
Enrollment
2,100 pts
Location
United States, Canada
Sponsor
Mayo Clinic
View Trial →
NCT06562543 Phase 4
Recruiting
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populati...
Condition
Colorectal Cancer
Enrollment
78 pts
Location
United States, Puerto Rico
Sponsor
Takeda
View Trial →
NCT07225023 N/A
Recruiting
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy...
Condition
Dizziness
Enrollment
100 pts
Location
United States
Sponsor
Northwestern University
View Trial →
NCT04380740 Phase 2
Recruiting
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxi...
Condition
Graft Vs Host Disease
Enrollment
160 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
Page 7 of 16 — 398 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology